Peer-influenced content. Sources you trust. No registration required. This is HCN.
Mayo Clinic
Take part in an engaging multidisciplinary discussion on the evolving dynamics of hepato-pancreatico-biliary cancers. Discover, learn, and prepare to integrate these new strategies into your clinical practice.
Oncology, Medical July 18th 2023
Cancer Therapy Advisor
Second-generation androgen receptor pathway inhibitors (ARPIs) have proven to be essential in managing nonmetastatic castration-resistant prostate cancer (nmCRPC). These treatments provide hope in delaying metastasis and improving overall survival, significantly altering the disease’s prognosis.
OBR Oncology
The potential removal of the DIEP flap’s unique medical billing code by CMS could pose significant barriers to this beneficial breast reconstruction option, prompting calls for its preservation to ensure continued access and patient choice. Dive in to explore the implications of this pivotal issue for breast cancer patients and the health care system.
Oncology, Surgical July 10th 2023
ASCO and SGO have taken a proactive stance on the chemotherapy drug shortage, issuing comprehensive guidelines to aid physicians in treating six specific cancers, ensuring that the crisis does not impede effective patient care.
Oncology, Medical July 10th 2023
Cleveland Clinic Journal of Medicine
As we continue to improve the sensitivity of breast imaging, the need for surgical excision of benign proliferative lesions diagnosed on core needle biopsy remains a contentious topic, calling for careful examination of acceptable excision thresholds, patient preferences, and potential disparities in care.
NEJM Evidence
Explore how the persistence of detectable Epstein-Barr virus DNA can serve as a significant predictive marker for nasopharyngeal cancer, potentially revolutionizing early diagnosis and improving survival rates.
Oncology, Medical July 3rd 2023